Mycophenolic Acid is an immunosuppressant indicated for the prophylaxis of organ rejection in adults receiving kidney transplant, and for the prophylaxis of organ rejection in pediatric patients >5 years who are at least 6 months post kidney transplant.
Mycophenolic Acid exhibits a cytostatic effect on T- and B-lymphocytes by inhibiting inosine monophosphate dehydrogenase (IMPDH). Blocking this pathway inhibits de novo guanosine nucleotide synthesis, therefore suppressing T- and B-lymphocyte proliferation.
Mylan’s Mycophenolic Acid Delayed-Release Tablets are available in 180mg and 360mg dosage strengths.
For more information call (800) RX-MYLAN or visit Mylan.com.